ENDRA Life Sciences Inc.
General ticker "NDRA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.6M (TTM average)
ENDRA Life Sciences Inc. follows the US Stock Market performance with the rate: 30.6%.
Estimated limits based on current volatility of 6.3%: low 5.32$, high 6.04$
Factors to consider:
- Total employees count: 21 (0.0%) as of 2023
- Top business risk factors: Operating losses and capital needs, Labor/talent shortage/retention, Geopolitical risks, Marketing and distribution challenges, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.81$, 31.63$]
- 2025-12-31 to 2026-12-31 estimated range: [1.22$, 8.79$]
Financial Metrics affecting the NDRA estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -116.90 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term NDRA quotes
Long-term NDRA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $13.16MM | $10.52MM | $10.82MM |
| Operating Income | $-13.16MM | $-10.52MM | $-10.82MM |
| Non-Operating Income | $-0.02MM | $0.46MM | $-0.69MM |
| R&D Expense | $6.55MM | $5.00MM | $3.19MM |
| Income(Loss) | $-13.18MM | $-10.06MM | $-11.51MM |
| Profit(Loss)* | $-13.18MM | $-10.06MM | $-11.51MM |
| Stockholders Equity | $7.20MM | $5.66MM | $2.56MM |
| Inventory | $2.64MM | $0.00MM | $0.00MM |
| Assets | $9.27MM | $6.75MM | $4.45MM |
| Operating Cash Flow | $-12.77MM | $-9.55MM | $-7.40MM |
| Capital expenditure | $0.20MM | $0.03MM | $0.02MM |
| Investing Cash Flow | $-0.20MM | $-0.02MM | $-0.01MM |
| Financing Cash Flow | $8.40MM | $7.52MM | $7.81MM |
| Earnings Per Share** | $-6.83 | $-5.89 | $-10.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.